| Literature DB >> 24039761 |
Lijun Qin1, Yaosheng Chen, Xiaohong Liu, Sanxing Ye, Kaifan Yu, Zheng Huang, Jingwei Yu, Xingyu Zhou, Hu Chen, Delin Mo.
Abstract
Pig is an important agricultural animal for meat production and provides a valuable model for many human diseases. Functional studies have demonstrated that microRNAs (miRNAs) play critical roles in almost all aspects of skeletal muscle development and disease pathogenesis. To investigate the miRNAs involved in regulating different periods of skeletal muscle development, we herein performed a comprehensive research for porcine microRNAome (miRNAome) during 10 skeletal muscle developmental stages including 35, 49, 63, 77, 91 dpc (days post coitum) and 2, 28, 90, 120, 180 dpn (days postnatal) using Solexa sequencing technology. Our results extend the repertoire of pig miRNAome to 247 known miRNAs processed from 210 pre-miRNAs and 297 candidate novel miRNAs through comparison with known miRNAs in the miRBase. Expression analysis of the 15 most abundant miRNAs in every library indicated that functional miRNAome may be smaller and tend to be highly expressed. A series of muscle-related miRNAs summarized in our study present different patterns between myofibers formation phase and muscle maturation phase, providing valuable reference for investigation of functional miRNAs during skeletal muscle development. Analysis of temporal profiles of miRNA expression identifies 18 novel candidate myogenic miRNAs in pig, which might provide new insight into regulation mechanism mediated by miRNAs underlying muscle development.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24039761 PMCID: PMC3770649 DOI: 10.1371/journal.pone.0072418
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Basic analysis of Sequencing data.
A–B. Sequence length distribution of known miRNAs (A) and small RNAs (B); C. Count number distribution of Total Reads (left) and Unique Small RANs (right).
The top most abundant 15 miRNAs in each library.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ssc-miR-1 | 2103431.74 | 14168.38 | 79554.80 | 117686.25 | 126702.52 | 119640.12 | 142618.55 | 218084.74 | 310634.60 | 402667.63 | 571674.13 |
| 2 | ssc-miR-378 | 1625963.19 | 19043.59 | 104583.43 | 93292.67 | 101497.98 | 121417.03 | 283735.95 | 329605.58 | 377885.10 | 79332.57 | 115569.27 |
| 3 | ssc-miR-143-3p | 1176846.35 | 85966.88 | 97786.87 | 101871.98 | 126658.26 | 132892.15 | 150534.02 | 172399.50 | 96310.23 | 112916.20 | 99510.27 |
| 4 | ssc-miR-133a-3p | 607495.75 | 2727.83 | 15804.31 | 26969.46 | 18529.50 | 53763.56 | 92575.68 | 73767.14 | 80230.65 | 160502.23 | 82625.41 |
| 5 | ssc-miR-30a-5p | 531375.43 | 96303.29 | 82081.00 | 114727.74 | 91093.80 | 66594.81 | 29197.53 | 22315.70 | 10041.35 | 12723.78 | 6296.41 |
| 6 | ssc-miR-206 | 486805.67 | 14430.69 | 58818.28 | 70883.78 | 80508.60 | 114389.28 | 53764.91 | 31347.29 | 18392.07 | 28534.43 | 15736.34 |
| 7 | ssc-let-7f | 317168.48 | 14823.77 | 51717.88 | 51980.72 | 53943.49 | 51279.82 | 19763.81 | 17837.04 | 12813.37 | 25372.54 | 17636.05 |
| 8 | ssc-miR-148a | 253477.02 | 48633.91 | 62835.68 | 30149.73 | 58289.18 | 25638.64 | 12373.55 | 5875.23 | 4296.70 | 3018.60 | 2365.82 |
| 9 | ssc-miR-10b | 234732.07 | 55274.96 | 42326.43 | 30113.66 | 23607.22 | 21081.96 | 14529.22 | 14327.48 | 10202.41 | 13349.09 | 9919.64 |
| 10 | ssc-miR-127 | 214267.02 | 11872.22 | 62283.84 | 56300.94 | 44626.90 | 20717.40 | 10194.69 | 4062.24 | 1229.49 | 2479.72 | 499.59 |
| 11 | ssc-miR-140* | 187553.50 | 163247.38 | 4841.03 | 4036.55 | 4056.84 | 2828.27 | 1901.68 | 1341.56 | 893.49 | 2227.68 | 2179.02 |
| 12 | ssc-miR-30d | 172056.17 | 31767.19 | 29605.00 | 30624.26 | 20723.44 | 20029.29 | 15681.53 | 10186.79 | 4142.37 | 6753.67 | 2542.63 |
| 13 | ssc-miR-542-3p | 155142.75 | 20257.32 | 32769.39 | 36970.07 | 30137.30 | 18650.10 | 6800.57 | 4061.40 | 1364.72 | 3414.29 | 717.59 |
| 14 | ssc-miR-21 | 131742.03 | 32846.54 | 22577.72 | 16102.99 | 19634.04 | 12044.42 | 5700.21 | 5369.31 | 7447.14 | 6139.29 | 3880.37 |
| 15 | ssc-let-7a | 121288.75 | 12151.08 | 18169.62 | 17302.43 | 20377.25 | 19469.48 | 8340.53 | 7167.23 | 4962.23 | 8175.71 | 5173.18 |
| 16 | ssc-miR-30e-5p | 87618.91 | 20876.82 | 14889.87 | 15178.98 | 11951.46 | 7061.26 | 5816.45 | 3735.71 | 1871.88 | 4270.27 | 1966.20 |
| 17 | ssc-miR-101 | 75739.16 | 10927.72 | 10465.49 | 11372.56 | 10378.67 | 8792.07 | 9002.56 | 4594.39 | 2650.42 | 4438.02 | 3117.25 |
| 18 | ssc-miR-10a | 73489.75 | 54439.05 | 6034.88 | 3408.41 | 2594.58 | 1945.94 | 1289.80 | 1131.32 | 476.95 | 1178.30 | 990.51 |
| 19 | ssc-miR-26a | 70050.82 | 4336.72 | 5112.43 | 5343.07 | 6004.85 | 8431.37 | 9595.40 | 6413.11 | 5718.05 | 11470.45 | 7625.36 |
| 20 | ssc-miR-103 | 64540.89 | 24347.45 | 11077.11 | 6324.15 | 6941.08 | 6807.53 | 3326.21 | 1585.72 | 1207.70 | 2095.07 | 828.87 |
| 21 | ssc-miR-30c | 58032.92 | 6600.70 | 4842.93 | 5957.25 | 4372.65 | 6574.03 | 8852.00 | 4789.69 | 4229.47 | 8277.57 | 3536.63 |
| 22 | ssc-miR-133b | 57966.15 | 1095.91 | 3365.47 | 4991.24 | 4548.17 | 11303.05 | 11654.61 | 3570.98 | 3863.09 | 9805.15 | 3768.48 |
| 23 | ssc-miR-411 | 35786.91 | 625.66 | 3329.22 | 5246.32 | 5586.72 | 11947.48 | 4728.62 | 369.80 | 137.92 | 3719.29 | 95.87 |
| 24 | ssc-miR-30e-3p | 35683.28 | 5911.43 | 5695.56 | 3643.81 | 2647.77 | 2052.03 | 2131.20 | 4285.46 | 3967.09 | 1926.72 | 3422.21 |
| 25 | ssc-miR-9-2 | 28464.42 | 27754.31 | 103.78 | 63.66 | 31.91 | 27.52 | 12.07 | 5.86 | 17.92 | 178.08 | 269.31 |
| 26 | ssc-miR-9-1 | 28464.22 | 27754.31 | 103.40 | 63.33 | 32.18 | 27.79 | 11.86 | 5.86 | 18.09 | 178.67 | 268.70 |
| 27 | ssc-miR-30b-5p | 28196.90 | 1534.35 | 1614.82 | 2019.87 | 1761.57 | 2834.33 | 5252.29 | 3199.22 | 2536.32 | 5126.60 | 2317.53 |
Information of miRNAs known to function in muscle development (muscle-related miRNAs).
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| MyoD [ | miR-1 | up-regulation | HDAC4 [ | down-regulation | C2C12, skeletal muscle, cardiac muscle, smooth muscle, Rhabdomyosarcoma |
| HMOX1 [ | down-regulation | Notch3 [ | down-regulation | ||
| Myogenin [ | miR-133 | up-regulation | SRF [ | down-regulation | C2C12, skeletal muscle, cardiac muscle, Rhabdomyosarcoma |
| HMOX1 [ | down-regulation | down-regulation | |||
| Myogenin [ | miR-206 | up-regulation | Cx43 [ | down-regulation | C2C12, skeletal muscle, Rhabdomyosarcoma, laryngeal squamous cell carcinoma (LSCC) |
| TGF-β [ | down-regulation | Notch3 [ | down-regulation | ||
| MyoD [ | miR-378 | up-regulation | MyoR [ | down-regulation | C2C12, skeletal muscle[ |
| IGF1 [ | down-regulation | IGF1R [ | down-regulation | cardiac muscle | |
| miR-155 | MEF2A [ | down-regulation | skeletal muscle[ | ||
| KDM2B (Ndy1/FBXL10/JHDM1B) [ | let-7/miR-101 | down-regulation | EZH2 [ | down-regulation | skeletal muscle |
| let-7b | GHR [ | down-regulation | |||
| STAT3 [100] | miR-124a | up-regulation | embryonic stem cell (ESC) | ||
| mTOR [ | miR-125 | down-regulation | IGF-II [ | down-regulation | skeletal muscle, smooth muscle, ESC |
| miR-126 | Spred-1 [ | down-regulation | cardiac muscle, ESC | ||
| miR-128a | PPARγ [ | down-regulation | skeletal muscle | ||
| miR-130a | GAX [ | down-regulation | vascular endothelial cells (ECs) | ||
| miR-135 | Smad5 [ | down-regulation | C2C12, Hodgkin lymphoma | ||
| SRF [ | miR-143/145 | up-regulation | SRF [ | down-regulation | smooth muscle |
| miR-144 | IRS1 [ | down-regulation | Type II diabetes mellitus | ||
| miR-148a | ROCK1 [ | down-regulation | skeletal muscle | ||
| miR-15a | DLK1 [ | down-regulation | 3T3-L1 preadipocytes | ||
| miR-15a/16 | cyclin D1 [ | down-regulation | skeletal muscle | ||
| miR-181 | Hox-A11 [ | down-regulation | skeletal muscle, ESC | ||
| miR-199a | Hif-1α [ | down-regulation | cardiac muscle | ||
| miR-204 | Runx2 [ | down-regulation | smooth muscle | ||
| miR-208a | Thrap1 [ | down-regulation | cardiac muscle | ||
| miR-208b/499 | Sox6 [ | down-regulation | muscle | ||
| TGF-β/BMPs signaling [ | miR-21 | up-regulation | PTEN [ | down-regulation | skeletal muscle, cardiac muscle, smooth muscle |
| Hif1a [ | miR-210 | up-regulation | cardiac muscle | ||
| Myogenin [ | miR-214 | up-regulation | Ezh2 [ | down-regulation | C2C12, skeletal muscle, ESC |
| Ras-MAPK pathway [ | miR-221 | up-regulation | p27 [ | down-regulation | skeletal muscle, mesenchymal cells |
| Ras-MAPK pathway [ | miR-222 | up-regulation | p27 [ | down-regulation | skeletal muscle |
| NFATc3 [ | miR-23a | MAFbx/atrogin-1 [ | down-regulation | skeletal muscle | |
| TGF-β [ | miR-24 | down-regulation | skeletal muscle | ||
| C/EBPα [ | miR-26a | up-regulation | GSK-3β [ | down-regulation | skeletal muscle, smooth muscle |
| Pitx2 [ | miR-27a/b | down-regulation | MSTN [ | down-regulation | skeletal muscle |
| NF-kappa-B-YY1 [ | miR-29 | down-regulation | HDAC4 [ | down-regulation | C2C12, skeletal muscle, cardiac muscle, Aneurysm |
| miR-30 | CTGF [ | down-regulation | cardiac muscle | ||
| miR-31 | Myf5 [ | down-regulation | skeletal muscle, Duchenne muscular dystrophy | ||
| miR-320 | PFKm [ | down-regulation | muscle | ||
| miR-322/424 | Cdc25A [ | down-regulation | skeletal muscle | ||
| miR-351 | E2f3 [ | down-regulation | skeletal muscle | ||
| SRF [ | miR-486 | up-regulation | PTEN [ | down-regulation | skeletal muscle |
| miR-489 | Dek [ | down-regulation | skeletal muscle | ||
| miR-494 | mtTFA [ | down-regulation | skeletal muscle | ||
| miR-503 | Cdc25A [ | down-regulation | skeletal muscle | ||
| miR-546 | Mybbp1a [ | down-regulation | skeletal muscle | ||
| miR-669a/669q | MyoD [ | down-regulation | skeletal muscle | ||
| miR-696 | PGC-1α [ | down-regulation | skeletal muscle | ||
| STAT3 [100] | miR-9 | up-regulation | ESCs | ||
| miR-92a | up-regulation | integrin α5 [ | down-regulation | muscle, Ecs |
Identified in pig
Potential target
The numbers of differentially expressed miRNAs between libraries.
|
| |||
|---|---|---|---|
|
|
|
|
|
| LR2/1 | 75 | 38 | 37 |
| LR3/2 | 9 | 2 | 7 |
| LR4/3 | 15 | 4 | 11 |
| LR5/4 | 20 | 15 | 5 |
| LR6/5 | 61 | 7 | 54 |
| LR7/6 | 74 | 5 | 69 |
| LR8/7 | 47 | 8 | 39 |
| LR9/8 | 118 | 116 | 2 |
| LR10/9 | 105 | 1 | 104 |
LR, Landrace; DE, differentially expressed(P<0.01│log2fold-change│>2); up, up regulation; down, down regulation
Figure 2Comparison of differentially expressed (DE) miRNAs among three data sets.
The number marked in the overlapping areas shows the common DE miRNAs.
Figure 3KEGG Orthology analysis of the most abundant miRNAs.
A. 31 significantly enriched KEGG pathways were achieved using the target genes of the most abundant 25 miRNAs (not including let-7 family) in ten libraries; B. comparison of KEGG pathways significantly enriched during skeletal muscle development at 35 to 77dpc (LR 1-4), 77dpc to 28 dpn (LR 4-7) and 28 to 180 dpn (LR 7-10). P-value < 0.01.
KEGG Orthology enriched for target genes of DE miRNAs between different libraries.
|
|
|
|
|
|
|
|
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Adherens junction | * | ** | * | * | * | * | ** | * | ** | ** | ||||||||
| Adipocytokine signaling pathway | * | * | * | * | ** | * | ||||||||||||
| Axon guidance | * | ** | * | ** | * | ** | * | ** | * | ** | ** | ** | ** | ** | ** | |||
| Calcium signaling pathway | * | ** | * | ** | * | ** | ** | |||||||||||
| Chemokine signaling pathway | * | * | * | |||||||||||||||
| ErbB signaling pathway | ** | ** | * | ** | ** | * | ** | ** | ** | |||||||||
| Focal adhesion | ** | ** | * | ** | * | ** | ** | ** | ** | ** | ** | ** | ** | |||||
| Gap junction | ** | ** | ** | * | ** | ** | * | ** | ** | * | ||||||||
| GnRH signaling pathway | ** | ** | * | * | * | ** | * | * | ** | ** | ** | ** | ||||||
| Hedgehog signaling pathway | * | * | * | * | * | |||||||||||||
| Insulin signaling pathway | ** | ** | ** | ** | ** | ** | ** | ** | ** | |||||||||
| MAPK signaling pathway | ** | ** | * | ** | ** | ** | ** | ** | ||||||||||
| Melanogenesis | ** | ** | ** | ** | * | ** | ** | ** | ** | ** | ** | * | ** | ** | ** | |||
| mTOR signaling pathway | * | ** | * | * | * | |||||||||||||
| Neurotrophin signaling pathway | ** | ** | ** | * | ** | ** | * | ** | ** | ** | ** | ** | ** | |||||
| Notch signaling pathway | ** | |||||||||||||||||
| p53 signaling pathway | * | * | * | * | * | * | ||||||||||||
| Phosphatidylinositol signaling system | * | * | ** | ** | * | * | ||||||||||||
| T cell receptor signaling pathway | ** | * | ** | ** | ** | |||||||||||||
| TGF-beta signaling pathway | ** | * | ** | * | * | ** | ** | ** | ** | ** | ** | |||||||
| VEGF signaling pathway | * | |||||||||||||||||
| Wnt signaling pathway | ** | ** | ** | * | ** | * | ** | * | ** | ** | ** | ** | ** | |||||
Asterisk indicated the significant enrichment of KEGG pathways (* p valued <0.05; **p value < 0.01)
Figure 4Clustering of miRNA expression profiles.
A–B. Each box corresponded to a model expression profile and only colored profiles reached statistical significance. The upper-left number in the box gave information about the order of profile (upper left) and the p-value significance (bottom left). A. 26 clusters of 87 DE miRNAs during myofiber formation, the first three of which showed statistically significant; B. 50 clusters of 166 DE miRNAs during myofiber maturation, the first two of which showed statistically significant. C. Five significant clusters of miRNA profiles during myofiber formation (cluster 1-3) and myofiber maturation (cluster 4-5) were displayed as time course plots of log 2miRNA expression ratios to controls.
Figure 5Expression profiles of candidate myogenic miRNAs.
Based on STEM results, DE miRNAs that had similar expression profiles with muscle-related miRNAs were selected and clustered into six distinctive types of expression patterns during muscle development.
Figure 6Validation of the sequencing data using Real-time PCR method.
The fold changes in abundance of night random miRNAs in 10 libraries were normalized by comparing with the LR1.The r value indicates the Pearson Correlation Coefficient between the two methods.